These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7401458)

  • 1. Improving anemia by hemodialysis: effect of serum erythropoietin.
    Radtke HW; Frei U; Erbes PM; Schoeppe W; Koch KM
    Kidney Int; 1980 Mar; 17(3):382-7. PubMed ID: 7401458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis.
    Chandra M; McVicar M; Clemons G; Mossey RT; Wilkes BM
    Nephron; 1987; 46(3):312-5. PubMed ID: 3627325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function.
    Radtke HW; Claussner A; Erbes PM; Scheuermann EH; Schoeppe W; Koch KM
    Blood; 1979 Oct; 54(4):877-84. PubMed ID: 476305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained negative feedback between haematocrit and serum erythropoietin concentration in end-stage renal failure.
    Erbes PM; Radtke HW; Schoeppe W; Koch KM
    Proc Eur Dial Transplant Assoc; 1978; 15():442-8. PubMed ID: 740677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
    Rao DS; Shih MS; Mohini R
    N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma erythropoietin and hematocrit under the influence of chronic hemodialysis treatment (author's transl)].
    Schulz E; Mödder B; Rath K
    Klin Wochenschr; 1977 Jan; 55(2):65-9. PubMed ID: 834018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure.
    McGonigle RJ; Husserl F; Wallin JD; Fisher JW
    Kidney Int; 1984 Feb; 25(2):430-6. PubMed ID: 6727138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of acetate and bicarbonate hemodialysis on the plasma erythropoietin concentration in patients with chronic renal failure.
    Wiecek A; Franek E; Kokot F; Rudka R
    Int J Artif Organs; 1997 Feb; 20(2):108-11. PubMed ID: 9093890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and anemia in chronic renal failure.
    Pavlović-Kentera V; Clemons GK; Djukanović L; Biljanović-Paunovic L
    Exp Hematol; 1987 Aug; 15(7):785-9. PubMed ID: 3609182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of increased hemodialysis dose on endogenous erythropoietin production in end-stage renal disease.
    Ifudu O; Friedman EA
    Nephron; 1998; 79(1):50-4. PubMed ID: 9609462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum erythropoietin levels and hematocrit in end-stage renal disease: influence of the mode of dialysis.
    Chandra M; Clemons GK; McVicar M; Wilkes B; Bluestone PA; Mailloux LU; Mossey RT
    Am J Kidney Dis; 1988 Sep; 12(3):208-13. PubMed ID: 3414676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin and improvement of anemia in long-term hemodialysis patients.
    Dukanovic L; Clemons GK; Ikonomovski J; Biljanovic-Paunović L; Pavlović-Kentera V
    Acta Med Iugosl; 1991; 45(2):151-60. PubMed ID: 1887810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients.
    Chandra M; Miller ME; Garcia JF; Mossey RT; McVicar M
    Nephron; 1985; 39(1):26-9. PubMed ID: 3969187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of recombinant human erythropoietin on the bone marrow picture in patients with chronic renal failure treated by hemodialysis].
    Sułowicz W; Hanicki Z; Skotnicki AB; Wójcik J; Sydor A
    Przegl Lek; 1992; 49(3):88-90. PubMed ID: 1438902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC; Korst DR
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
    Boratyńska M; Szewczyk Z; Szepietowski T; Czyz W; Cybulski K; Bogucki J; Szczepański J
    Przegl Lek; 1990; 47(11):741-5. PubMed ID: 2098840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].
    Cuero CJ; Pérez Guardia E; de Rivera C
    Rev Med Panama; 1996; 21(1-2):55-9. PubMed ID: 8966240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.